Description:
Sograzepide, a benzodiazepin derivative, has been found to be a gastric receptor as well as CCK2 receptor antagonist that could be useful against chronic atrophic gastritis and gastric carcinoid at some extent.
- Molecular Weight:498.58
- Purity:≥ 95% (HPLC)
Molecular Formula:
C28H30N6O3
Canonical SMILES:
CC(C)(C)C(=O)CN1C2=CC=CC=C2C(=NC(C1=O)NC(=O)NC3=CC(=CC=C3)NC)C4=CC=CC=N4
InChI:
InChI=1S/C28H30N6O3/c1-28(2,3)23(35)17-34-22-14-6-5-12-20(22)24(21-13-7-8-15-30-21)32-25(26(34)36)33-27(37)31-19-11-9-10-18(16-19)29-4/h5-16,25,29H,17H2,1-4H3,(H2,31,33,37)/t25-/m0/s1
InChIKey:
YDZYKNJZCVIKPP-VWLOTQADSA-N
Appearance:
Solid
Storage: Store in a cool and dry place and at 0 - 4 °C for short term (days to weeks) or -20 °C for long term (months to years).
Synonyms:
YF476; YF-476; YF 476; Netazepide; Sograzepide; UNII-HOU4I0G29C; YF 476; CHEMBL324547; 1-[(3R)-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-3-[3-(methylamino)phenyl]urea Weitere Informationen finden Sie
hier